Expert consensus on diabetes mellitus after solid organ transplantation in adults
10.3969/j.issn.1674-7445.2023110
- VernacularTitle:成人实体器官移植后糖尿病管理专家共识
- Author:
Yan BI
1
;
Bin LU
1
;
ORGAN TRANSPLANTATION AND REHABILITATION COMMITTEE OF CHINESE MEDICAL ASSOCIATION OF REHABILITATION
1
Author Information
1. .
- Publication Type:GuidelineandConsensus
- Keywords:
Post-transplant diabetes mellitus;
Solid organ transplantation;
Immunosuppressors;
Antidiabetics
- From:
Organ Transplantation
2023;14(5):623-642
- CountryChina
- Language:Chinese
-
Abstract:
Post-transplant diabetes mellitus (PTDM) is a common endocrine and metabolic disorder after adult solid organ transplant (SOT), affecting 10% to 40% of recipients. PTDM has been associated with increased mortality, heightened risk of infections, graft-related complications and cardiovascular diseases, all of which seriously threaten the quality of life and long-term survival of recipients. According to recent studies and the domestic healthcare system, this consensus provides a comprehensive overview of the epidemiology, risk factors, pathogenesis, screening and diagnosis, treatments, prevention strategies, cardiovascular risk factor management and microvascular complications associated with PTDM, in order to further standardize the diagnosis and treatment of PTDM. The objective is to standardize the comprehensive management of PTDM with the aim of enhancing the long-term quality of life and clinical outcomes for SOT recipients.
